Presenting at a panel
·
2 Min Read

AMA backs in-person import of Canadian Rx if safety is assured

Allowing the practice offers patients an option to lower patient out-of-pocket spending on prescription drugs, which addresses a barrier to medication adherence: unaffordability.

Behavioral Health
·
8 Min Read

Nov. 1, 2018: National Advocacy Update

Trump administration on drug prices, FTC and insulin prices and more in the latest from AMA's national advocacy news.

Advocacy Update
·
1 Min Read

AMA statement on president’s plan for prescription drugs

Physicians share their patients’ concerns with the cost of prescription drugs. We appreciate the Trump Administration addressing this important issue.

Press Releases
The White House
·
4 Min Read

10 ways the new opioids law could help address the epidemic

The president signs into law a bill that expands access for opioid-use disorder treatment and prevention, and authorizes outpatient treatment alternative payment model.

Behavioral Health
·
2 Min Read

Oct. 18, 2018: Advocacy spotlight on Pennsylvania removes prior authorization for opioid treatment

Pennsylvania Gov. Wolf announced an agreement with major insurers to end prior authorization. Read about AMA's fight for medication-assisted treatment (MAT).

Advocacy Update
·
10 Min Read

Oct. 18, 2018: National Advocacy Update

Drug prices in TV ads, Surgeon General's opioid report and more in the latest AMA national health care advocacy news.

Advocacy Update
·
1 Min Read

AMA on proposal to increase transparency in drug ads

While AMA is opposed to consumer advertising of prescription drugs, since the practice is allowed, ads should come with at least a small dose of transparency.

Press Releases
·
4 Min Read

Understanding the opioid epidemic’s economic toll

Nearly 70,000 people died from drug-related overdose between January 2017 and January 2018, according to the Centers for Disease Control and Prevention, with about 48,000 related to opioids, the majority of which is due to heroin and illicit fentanyl.  

Behavioral Health
·
3 Min Read

Pennsylvania removes prior authorization for opioid treatment

Pennsylvania and seven major health insurance companies agreed today to remove prior authorization requirements for treatment of substance use disorders.

Press Releases